Struggling GlaxoSmithKline rips into RTP R&D group in global reorganization – FierceBiotech
0
Hobbled by sliding sales of Advair, GlaxoSmithKline’s U.S. group started to chop away at its large organization in North Carolina and Philadelphia on Wednesday as Glaxo’s North American chief Deirdre Connelly began to outline exactly where the axe will fall.
Read more – FierceBiotech